Chief Business Development Off of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Benzeno Sharon, sells 417 shares worth $24,661
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 07:00 PM, company Chief Business Development Off, Benzeno Sharon disclosed selling 417 shares at a cost of $59.14. At the time of this transaction (Dec 21), this trade was worth $24,661 in total. As of Dec 21, Benzeno Sharon now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) Chief Business Development Off, Benzeno Sharon, we have the following information:
- SEC Form 4 filing: Dec 01: Sold 6,770 shares at the rate of $48.87 per share. Total worth of this trade was $330,856. Total number of shares owned as of Dec 01 were 0
- SEC Form 4 filing: Nov 19: Sold 416 shares at the rate of $48.86 per share. Total worth of this trade was $20,326. Total number of shares owned as of Nov 19 were 0
- SEC Form 4 filing: Nov 02: Sold 6,772 shares at the rate of $45.58 per share. Total worth of this trade was $308,642. Total number of shares owned as of Nov 02 were 0
Posted by
George Daniels
on Thursday December 24 2020, 9:32 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
